India · Delayed Price · Currency is INR GPT Healthcare Statistics
Total Valuation
GPT Healthcare has a market cap or net worth of INR 11.90 billion. The enterprise value is 12.35 billion.
| Market Cap | 11.90B |
| Enterprise Value | 12.35B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Nov 12, 2026 |
Share Statistics
GPT Healthcare has 82.05 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 82.05M |
| Shares Outstanding | 82.05M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 14.66% |
| Float | 26.93M |
Valuation Ratios
The trailing PE ratio is 22.85.
| PE Ratio | 22.85 |
| Forward PE | n/a |
| PS Ratio | 2.33 |
| PB Ratio | 4.17 |
| P/TBV Ratio | 4.18 |
| P/FCF Ratio | 24.88 |
| P/OCF Ratio | 14.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.03, with an EV/FCF ratio of 25.82.
| EV / Earnings | 23.71 |
| EV / Sales | 2.42 |
| EV / EBITDA | 14.03 |
| EV / EBIT | 17.51 |
| EV / FCF | 25.82 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.25 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.04 |
| Debt / FCF | 1.92 |
| Interest Coverage | 8.80 |
Financial Efficiency
Return on equity (ROE) is 19.32% and return on invested capital (ROIC) is 17.16%.
| Return on Equity (ROE) | 19.32% |
| Return on Assets (ROA) | 9.34% |
| Return on Invested Capital (ROIC) | 17.16% |
| Return on Capital Employed (ROCE) | 17.73% |
| Weighted Average Cost of Capital (WACC) | 6.53% |
| Revenue Per Employee | 2.40M |
| Profits Per Employee | 245,142 |
| Employee Count | 2,124 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 17.11 |
Taxes
In the past 12 months, GPT Healthcare has paid 143.95 million in taxes.
| Income Tax | 143.95M |
| Effective Tax Rate | 21.66% |
Stock Price Statistics
The stock price has increased by +1.61% in the last 52 weeks. The beta is 0.41, so GPT Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +1.61% |
| 50-Day Moving Average | 148.38 |
| 200-Day Moving Average | 142.84 |
| Relative Strength Index (RSI) | 54.31 |
| Average Volume (20 Days) | 72,532 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GPT Healthcare had revenue of INR 5.10 billion and earned 520.68 million in profits. Earnings per share was 6.34.
| Revenue | 5.10B |
| Gross Profit | 3.06B |
| Operating Income | 705.02M |
| Pretax Income | 664.64M |
| Net Income | 520.68M |
| EBITDA | 879.94M |
| EBIT | 705.02M |
| Earnings Per Share (EPS) | 6.34 |
Balance Sheet
The company has 466.91 million in cash and 916.61 million in debt, with a net cash position of -449.70 million or -5.48 per share.
| Cash & Cash Equivalents | 466.91M |
| Total Debt | 916.61M |
| Net Cash | -449.70M |
| Net Cash Per Share | -5.48 |
| Equity (Book Value) | 2.85B |
| Book Value Per Share | 34.81 |
| Working Capital | 209.97M |
Cash Flow
In the last 12 months, operating cash flow was 817.41 million and capital expenditures -339.28 million, giving a free cash flow of 478.13 million.
| Operating Cash Flow | 817.41M |
| Capital Expenditures | -339.28M |
| Depreciation & Amortization | 174.92M |
| Net Borrowing | -187.92M |
| Free Cash Flow | 478.13M |
| FCF Per Share | 5.83 |
Margins
Gross margin is 59.96%, with operating and profit margins of 13.81% and 10.20%.
| Gross Margin | 59.96% |
| Operating Margin | 13.81% |
| Pretax Margin | 13.02% |
| Profit Margin | 10.20% |
| EBITDA Margin | 17.24% |
| EBIT Margin | 13.81% |
| FCF Margin | 9.37% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 1.72%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 1.72% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.40% |
| FCF Payout Ratio | 42.90% |
| Buyback Yield | -0.06% |
| Shareholder Yield | 1.67% |
| Earnings Yield | 4.38% |
| FCF Yield | 4.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |